2, 7 or 70 Genes? What Determines the Value of Genetic Testing?
In Greece, public reimbursement for hereditary breast cancer testing generally covers just two genes. A European expert group proposes up to seven for routine first-line testing, while commercial panels can analyse dozens. How should we decide which genes are worth testing?
Read article